Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review

• Hoofdauteurs: Luis Buzón-Martín (Auteur), Ines Zollner-Schwetz (Auteur), Selma Tobudic (Auteur), Emilia Cercenado (Auteur), Jaime Lora-Tamayo (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2021-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Dalbavancin (DAL) is a lipoglycopeptide with bactericidal activity against a very wide range of Gram-positive microorganisms. It also has unique pharmacokinetic properties, namely a prolonged half-life (around 181 h), which allows a convenient weekly dosing regimen, and good diffusion in bone tissue...